Literature DB >> 11058205

Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

L A Mandell1, T J Marrie, R F Grossman, A W Chow, R H Hyland.   

Abstract

Community-acquired pneumonia (CAP) is a serious illness with a significant impact on individual patients and society as a whole. Over the past several years, there have been significant advances in our knowledge and understanding of the etiology of the disease, and an appreciation of problems such as mixed infections and increasing antimicrobial resistance. The development of additional fluoroquinolone agents with enhanced activity against Streptococcus pneumoniae has been important as well. It was decided that the time had come to update and modify the previous CAP guidelines, which were published in 1993. The current guidelines represent a joint effort by the Canadian Infectious Disease Society and the Canadian Thoracic Society, and they address the etiology, diagnosis and initial management of CAP. The diagnostic section is based on the site of care, and the treatment section is organized according to whether one is dealing with outpatients, inpatients or nursing home patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058205     DOI: 10.1155/2000/412616

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  16 in total

1.  Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10       Impact factor: 3.267

Review 2.  Review of macrolides and ketolides: focus on respiratory tract infections.

Authors:  G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.

Authors:  Margaret Ip; Shirley S L Chau; Fang Chi; Amy Qi; Raymond W M Lai
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 4.  Nursing home-associated pneumonia, hospital-acquired pneumonia and ventilator-associated pneumonia: the contribution of dental biofilms and periodontal inflammation.

Authors:  Krishnan Raghavendran; Joseph M Mylotte; Frank A Scannapieco
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

5.  Guidelinitis: A new syndrome?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-11

6.  Should azithromycin no longer be considered a drug of choice for community-acquired pneumonia because of its potential to cause cardiovascular death?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2013-09

7.  Outcomes in dogs with uncomplicated, presumptive bacterial pneumonia treated with short or long course antibiotics.

Authors:  Annie Wayne; Megan Davis; Virginia B Sinnott; Kiko Bracker
Journal:  Can Vet J       Date:  2017-06       Impact factor: 1.008

Review 8.  Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews.

Authors:  Elizabeth E Dawson-Hahn; Sharon Mickan; Igho Onakpoya; Nia Roberts; Matthew Kronman; Chris C Butler; Matthew J Thompson
Journal:  Fam Pract       Date:  2017-09-01       Impact factor: 2.267

9.  Usefulness of Gram stain for diagnosis of lower respiratory tract infection or urinary tract infection and as an aid in guiding treatment.

Authors:  E J Kuijper; J van der Meer; M D de Jong; P Speelman; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-25       Impact factor: 3.267

10.  Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.

Authors:  Brent W Kinder; Michelle M Freemer; Talmadge E King; Raymond F Lum; Joanne Nititham; Kim Taylor; Jeffrey C Edberg; S Louis Bridges; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.